Search Thermo Fisher Scientific
Value reimagined:
Unlocking ROI and efficiency in drug development
New research from the Tufts Center for the Study of Drug Development quantifies the positive value of aligning CDMO, CRO, clinical supply, and lab services through a single partner. The findings: streamlined execution, faster timelines, and up to 113x ROI.
Discover how Thermo Fisher Scientific can help you reduce complexity, gain benefits, and accelerate your unique drug development journey.
Our complete set of services can help take your molecule from research to market faster
We support your asset development with our combined CDMO and CRO expertise. Thermo Fisher Scientific offers an end-to-end suite of drug development and clinical services spanning drug substance and drug product manufacturing for small molecule, large molecule, and advanced therapies, clinical supply, clinical research, and commercialization.
Our unique fully end-to-end approach ensures collaboration across the drug development process, helping to enable increased speed, simplicity, and scalability.
Click on any of the above 3 drug development phases to learn how your journey can be accelerated.
Being an integrated CDMO and CRO, we provide you with expertise and unparalleled resources for all phases of your drug development and manufacturing, from early development through clinical research and commercialization
Decades of experience bringing innovative therapies to market globally
We recognize the need to continually evolve and closely partner with our customers to support them throughout their journey of bringing innovative medicines to market.
Selection of our awards
CDMO leadership awards
Recognized across 5 categories, Patheon Pharma Services, Thermo Fisher Scientific
CRO leadership awards
